Cellectis (CLLS) Share-based Compensation (2015 - 2026)

Cellectis' Share-based Compensation history runs 12 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 70.39% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $6.8 million (up 108.75% YoY), while the FY2025 annual figure was $6.1 million, up 92.93% from the prior year.
• Share-based Compensation was $1.7 million for Q1 2026 at Cellectis, down from $2.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.6 million in Q4 2023 to a low of -$2.7 million in Q3 2023.
• Historically, Share-based Compensation has averaged $1.3 million across 5 years, with a median of $1.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation surged 7620.0% in 2022, then sank 299.62% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $387000.0 in 2022, then jumped by 1094.06% to $4.6 million in 2023, then plunged by 80.87% to $884000.0 in 2024, then surged by 154.52% to $2.2 million in 2025, then retreated by 26.09% to $1.7 million in 2026.
• The last three Share-based Compensation figures came in at $1.7 million (Q1 2026), $2.2 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.